HepatologyNews.net

Hepatology Xagena

XagenaNewsletter
Medical Meeting
Xagena Mappa
Mediexplorer.it

Search results for "Sovaldi"

The results from four Phase 3 clinical trials ( NEUTRINO, FISSION, POSITRON and FUSION ) evaluating Sofosbuvir ( Sovaldi ), an investigational once-daily nucleotide NS5B inhibitor for the treatment of ...


The standard treatment for hepatitis C virus ( HCV ) infection is Interferon, which is administered subcutaneously and can have troublesome side effects.Researchers have evaluated Sofosbuvir ( Sovaldi ...


All-oral combination therapy is desirable for patients with chronic hepatitis C virus ( HCV ) infection. Researchers evaluated Daclatasvir ( an HCV NS5A replication complex inhibitor ) plus Sofosbuvir ...


Patients chronically infected with hepatitis C virus ( HCV ) genotype 2 or 3 for whom treatment with Peginterferon is not an option, or who have not had a response to prior interferon treatment, curre ...


In a study involving treatment-naive and treatment-experienced patients of Egyptian ancestry with chronic genotype 4 HCV infection, Sofosbuvir ( Sovaldi ) plus Ribavirin was shown to provide a simple, ...


A hepatitis C ( HCV ) drug currently under investigation, ABT-493 and ABT-530, which is an all-oral once-daily antiviral treatment, helped HCV genotype 3 patients with heavily scarred livers and no pr ...


Data has demonstrated that choosing a different combination of direct-acting antiviral ( DAA ) treatment for hepatitis C can eradicate the virus at four weeks in patients who had already failed on pre ...